Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis - Okushin, Kazuya; Ikeuchi, Kazuhiko; Saito, Makoto; Kishida, Toshiyuki; Kado, Akira; Fujishiro, Mitsuhiro; Moriya, Kyoji; Yotsuyanagi, Hiroshi; Koike, Kazuhiko; Tsutsumi, Takeya (Internal Medicine, 2025)
Keywords: Aged; Aged, 80 and over; chemoprevention; Cirrhosis; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 - mortality; COVID-19 Drug Treatment; Diabetes mellitus (non-insulin dependent); Female; Hepatitis; Hepatitis B; Hepatitis B, Chronic - complications; Hepatitis B, Chronic - drug therapy; Hepatitis C, Chronic - complications; Hepatitis C, Chronic - drug therapy; Hepatocellular carcinoma; Hospital Mortality; Humans; Male; Middle Aged; Mortality; novel coronavirus disease 2019; Original; Patients; Propensity Score; Retrospective Studies; SARS-CoV-2; Severe acute respiratory syndrome; severe acute respiratory syndrome coronavirus; Severity of Illness Index; Subclinical infection; Ursodeoxycholic acid; Ursodeoxycholic Acid - adverse effects; Ursodeoxycholic Acid - therapeutic use; severe acute respiratory syndrome coronavirus; chemoprevention; ursodeoxycholic acid; novel coronavirus disease 2019